Search for: "Cancel v. Watson"
Results 1 - 20
of 48
Sorted by Relevance
|
Sort by Date
2 Jun 2023, 12:02 am
Towers Watson & Co. v. [read post]
14 Dec 2009, 7:07 am
Watson (08-6261), and Carachuri-Rosendo v. [read post]
8 Sep 2015, 6:40 am
Watson, supra. [read post]
6 Sep 2021, 1:02 am
” “Today, women woke up to have their abortion appointments cancelled. [read post]
31 Oct 2015, 8:53 am
AMP cancelled the project and incurred substantial penalties as a result. [read post]
19 Oct 2015, 9:53 am
AMP’s member communities voted to cancel the project. [read post]
19 Apr 2023, 9:37 am
From Al Namani v. [read post]
5 Apr 2017, 9:08 am
In Novartis v. [read post]
16 Jun 2016, 8:50 am
Power, Inc. v. [read post]
10 Nov 2019, 4:38 pm
The leading phone hacking campaigner and Labour Deputy Leader Tom Watson MP has announced that he is standing down as an MP. [read post]
25 Aug 2020, 4:28 pm
See Latisha Watson v. [read post]
5 Apr 2017, 7:53 am
Watson Labs., Inc., 611 F. [read post]
5 May 2010, 4:46 am
Watson Laboratories, Inc. [read post]
4 Mar 2018, 4:04 pm
In accordance with its manifesto commitment the Government decided to cancel Leveson Part 2 and to repeal section 40 of the Crime and Courts Act 2013. [read post]
29 Mar 2007, 6:49 pm
Perhaps the most interesting decision was Hurley v. [read post]
4 Oct 2009, 3:35 pm
(See prior related posting.)In Watson v. [read post]
10 Feb 2015, 2:51 pm
The facts, from Pacheco v. [read post]
1 May 2009, 9:00 am
Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement suit over Barr’s ANDA to manufacture generic Alimta (Patent Docs) Arthrotech (Diclofenac/Misoprostol) – US: Pfizer files patent infringement suit against Teva over generic Arthrotech ANDA (Patent Docs) Enablex (Darifenacin hydrobromide) – US: Watson files ANDA to market generic Enablex prior to expiration of Novartis’ patent (GenericsWeb) Flanax (Naproxen)… [read post]
9 Mar 2010, 9:34 am
Justice MacLeod in Aram Systems Ltd. v. [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog) Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
